Atopic dermatitis: New insights and opportunities for therapeutic intervention

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 5, 2000, Pages 860-876

  Leung, Donald Y M ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

Allergy; Atopic dermatitis; Hypersensitivity; IgE; Keratinocytes; Skin; Superantigens; T cells

Indexed keywords

ALLERGEN; CHEMOATTRACTANT; CYTOKINE; IMMUNOGLOBULIN E; SUPERANTIGEN;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; ATOPIC DERMATITIS; HUMAN; HYPERSENSITIVITY; IMMUNOHISTOLOGY; KERATINOCYTE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN INFLAMMATION;

EID: 0034069636     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.106484     Document Type: Article

References (148)

1. 1. Leung DYM, Tharp M, Boguniewicz M. Atopic dermatitis. In: Freeberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al, cds. Dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1998. p1464-80.
2. 2. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Andersen R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999;103:125-38.
3. 3. Leung DYM. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999;104(Suppl):S99-108.
4. 4. Beltrani VS. The clinical spectrum of atopic dermatitis. J Allergy Clin Immunol 1999;104(Suppl):S87-98.
5. 5. Koblenzer CS. Itching and the atopic skin. J Allergy Clin Immunol 1999;104(Suppl):S109-13.
6. 6. Mihm MC Jr, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305-12.
7. 7. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Tmmunol 1999;104(Suppl):S114-22.
8. 8. Rukwied R, Heyer G. Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol 1999;8:39-45.
9. 9. Soter NA, Lewis RA, Corey EJ, Austen KF. Local effects of synthetic leukolrienes (LTC4, LTD4, LTE4, and LTB4) in human skin. J Invest Dermatol 1983;80:115-9.
10. 10. Tobin D, Nabarro G, Baart dela Faille H, van Vloten WA, van der Putte SCJ, Schuurman H-J. Increased number of immunoreactive nerve fibers in atopic dermatitis. J Allergy Clin Immunol 1992;90:613-22
11. 11. Wahlgren CF, Tengvall Linder M, Hagermark O, Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch Dermatol Res 1995;287:572-80.
12. 12. Hagermark O, Rajka G, Bergqvist U. Experimental itch in human skin elicited by rat mast cell chymase. Acta Derm Venereol (Stockh) 1972;52:125-8.
13. 13. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, et al. Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338:137-40.
14. 14. Pincelli C, Fantini F, Massimi P, Girolomoni G, Seidenari S, Giannetti A. Neuropeptides in skin from patients with atopic dermatitis: an immunohistochemical study. Br J Dermatol 1990;122:745-50.
15. 15. Nassif A, Chan SC, Storrs FJ, Hanifin JM. Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 1994;130:1402-7.
16. 16. Kodama A, Horikawa T, Suzuki T, Ajiki W, Takashima T, Harada S, et al. Effect of stress on atopic dermatitis: investigation in patients after the great Hanshin earthquake. J Allergy Clin Immunol 1999;104:173-6.
17. 17. Kusunoki T, Asai K, Harazaki M, Korematsu S, Hosoi S. Month of birth and prevalence of atopic dermatitis in schoolchildren: dry skin in early infancy as a possible etiologic factor. J Allergy Clin Immunol 1999;103:1148-52.
18. 18. Buffum WP, Settipane GA. Prognosis of asthma in childhood. Arch Pediatr Adolesc Med 1966;112:214-7.
19. 19. Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 1998;101:1614-22.
20. 20. Dworzak MN, Froschl G, Printz D, Fleischer C, Potschger U, Fritsch G, et al. Skin-associated lymphocytes in the peripheral blood of patients with atopic dermatitis: signs of subset expansion and stimulation. J Allergy Clin Immunol 1999;103:901-6.
21. 21. Shimada Y, Sato S, Hasegawa M, Tedder TF, Takehara K. Elevated serum L-selectin levels and abnormal regulation of L-selectin expression on leukocytes in atopic dermatitis: soluble L-selectin levels indicate disease severity. J Allergy Clin Immunol 1999;104:163-8.
22. 22. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-19.
23. 23. Kimura M, Tsuruta S, Yoshida T. Unique profile of IL-4 and IFN-gamma production by peripheral blood mononuclear ceils in infants with atopic dermatitis. J Allergy Clin Immunol 1998;102:238-44.
24. 24. Kimura M, Tsuruta S, Yoshida T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol 1998;101:84-9.
25. 25. Shimizu T, Abe R, Ohkawara A, Nishihira J. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol 1999;104:659-64.
26. 26. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. GM-CSF inhibition of monocyte apoptosis contributes to the chronic monocyte activation in atopic dermatitis. J Clin Invest 1995;95:211-8.
27. 27. Oettgen HC, Geha RS. IgE in asthma and atopy: cellular and molecular connections. J Clin Invest 1999;104:829-35.
28. 28. Nickel R, Beck LA, Stellato C, Schleimer RP. Chemokines and allergic disease. J Allergy Clin Immunol 1999;104:723-42.
29. 29. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996;272:60-6.
30. 30. Picker LJ, Martin RJ, Trumble A, Newman LS, Collins PA, Bergstresser PR, et al. Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites. Eur J Immunol 1994;24:1269-77.
31. 31. Santamaria Babi LF, Picker LJ, Perez Soler MT, Drzimalla K, Flohr P, Blaser K, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen. J Exp Med 1995;181:1935-40.
32. 32. Akdis M, Akdis CA, Weigl L, Disch R, Blaser K. Skin-homing, CLA+ memory T cells are activated in atopic dermatitis and regulate IgE by an IL-13-dominated cytokine pattern: IgG4 counter-regulation by CLA-memory T cells. J Immunol 1997;159:4611-9.
33. 33. Akdis M, Simon HU, Weigl L, Kreyden O, Blaser K, Akdis CA. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis. J Immunol 1999;163:466-75.
34. 34. Leung DYM, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71:47-56.
35. 35. Leung DYM, Schneeberger EE, Siraganian RP, Geha RS, Bhan AK. The presence of IgE on macrophages and dendritic cells infiltrating into the skin lesion of atopic dermatitis. Clin Immunol Immunopathol 1987;42:328-37.
36. 36. Bruijnzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Derm Res 1986;287:199-205.
37. 37. Cheng JF, Ott NL, Peterson EA, George TJ, Hukee MJ, Gleich GJ, Leiferman KM. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J Allergy Clin Immunol 1997;99:683-92.
38. 38. Gleich GJ, Leiferman KM. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105:651-63.
39. 39. Pucci N, Lombardi E, Novembre E, Farina S, Bernardini R, Rossi E, et al. Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity. J Allergy Clin Immunol 2000;105:353-7.
40. 40. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
41. 41. Hamid Q, Naseer T, Minshall EM, Song YL, Boguniewicz M, Leung DYM. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol 1996;98:225-31.
42. 42. Grewe M, Bruijnzeel-Koomen CA, Schopf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 1998; 19:359-61.
43. 43. Taha RA, Leung DYM, Ghaffar O, Boguniewicz M, Hamid Q. In vivo expression of cytokine receptor mRNA in atopic dermatitis. J Allergy Clin Immunol 1998;102:245-50.
44. 44. Spergel JM, Mizoguchi E, Oettgen H, Bhan AK, Geha RS. Roles of Th1 and Th2 cytokines in a murine model of allergic dermatitis. J Clin Invest 1999;103:1103-11.
45. 45. Laberge S, Ghaffar O, Boguniewicz M, Center DM, Leung DYM, Hamid Q. Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis. J Allergy Clin Immunol 1998;102:645-50.
46. 46. Taha RA, Leung DYM, Minshall E, Boguniewicz M, Luster A, Hamid QA. Eotaxin and monocyte chemoattractant protein (MCP)-4 mRNA expression in acute versus chronic atopic dermatitis [abstract]. J Allergy Clin Immunol 1998;101(Suppl):946A.
47. 47. Yawalkar N, Uguccioni M, Scharer J, Braunwalder J, Karlen S, Dewald B, et al. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. J Invest Dermatol 1999;113:43-8.
48. 48. Morales J, Honey B, Vicari AP, Hudak S, Oldham E, Hedrick J, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory to T cells. Proc Natl Acad Sci U S A 1999;96:14470-5.
49. 49. Koro O, Furutani K, Hide M, Yamada S, Yamamoto S. Chemical mediators in atopic dermatitis: involvement of leukotriene B4 released by a type I allergic reaction in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999;103:663-70.
50. 50. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis: implications for sustained dendritic cell activation in the skin. J Clin Invest 1997;99:3009-17.
51. 51. Pastore S, Corinti S, La Placa M, Didona B, Girolomoni G. Interferon-gamma promotes exaggerated cytokine production in keratinocytes cultured from patients with atopic dermatitis. J Allergy Clin Immunol 1998;101:538-44.
52. 52. Yamada H, Matsukura M, Yudate T, Chihara J, Stingl G, Tezuka T. Enhanced production of RANTES, an eosinophil chemoattractant factor, by cytokine-stimulated epidermal keratinocytes. Int Arch Allergy Immunol 1997;114(1 Suppl):28-32.
53. 53. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994;30:535-46.
54. 54. Leung DYM, Harbeck R, Bina P, Reiser RF, Yang E, Morris DA, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993;92:1374-80.
55. 55. Bratton DL, May KR, Kailey JM, Doherty DE, Leung DYM. Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis. J Allergy Clin Immunol 1999;103:895-900.
56. 56. Nimmagadda SE , Spahn JD, Surs W, Szefler SJ, Leung DYM. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics. Am J Respir Crit Care Med 1997;155:87-93.
57. 57. Clayton MH, Leung DYM, Surs W, Szener SJ. Altered glucocorticoid binding in atopic dermatitis. J Allergy Clin Immunol 1995;96:421-3.
58. 58. Herrscher RF, Kasper C, Sullivan TJ. Endogenous cortisol regulates immunoglobulin E-dependent late phase reaction. J Clin Invest 1992;90:596-603.
59. 59. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, et al. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997;185:825-31.
60. 60. Dinarello CA. IL-18: a Th1 -inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999;103:11-24.
61. 61. Mekori YA, Metcalfe DD. Mast cell-T cell interactions. I Allergy Clin Immunol 1999;104:517-23.
62. 62. Forrest S, Dunn K, Elliott K, Fitzpatrick E, Fullerton J, McCarthy M, et al. Identifying genes predisposing to atopic dermatitis. J Allergy Clin Immunol. 1999;105:1066-70.
63. 63. Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998;35:502-4.
64. 64. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-5.
65. 65. Hanifin J, Chan S, Cheng J. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis. J Invest Dermatol 1996;107:51-6.
66. 66. Santamaria LF, Torres R, Gimenez-Arnau AM, Gimenez-Camarasa JM, Ryder H, Palacios JM, et al. Rolipram inhibits staphylococcal enterotoxin B-mediated induction of the human skin-homing receptor on T lymphocytes. J Invest Dermatol. 1999;113: 82-6.
67. 67. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995;80:707-18.
68. 68. Jirapongsananuruk O, Hofer MF, Trumble AE, Norris DA, Leung DYM. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol 1998;160:4622-7.
69. 69. Hofer MF, Jirapongsananuruk O, Trumble AE, Leung DYM. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol 1998;101:96-102.
70. 70. Ohki O, Yokozeki H, Katayama I, Umeda T, Azuma M, Okumura K, et al. Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol 1997;136:838-45.
71. 71. Hauser C, Snapper CM, Ohara J, Paul WE, Katz SI. T helper cells grown with hapten-modified cultured Langerhans: cells produce interleukin 4 and stimulate IgE production by B cells. Eur J Immunol 1989;19:2435-51.
72. 72. Novak N, Haberstok J, Geiger E, Bieber T. Dendritic cells in allergy. Allergy 1999;54:792-803.
73. 73. Kraft S, Wessendorf JH, Hanau D, Bieber T. Regulation of the high affinity receptor for IgE on human epidermal Langerhans cells. J Immunol 1998;161:1000-6.
74. 74. Jurgens M, Wollenberg A, Hanau D, de la Salle H, Bieber T. Activation of human epidermal Langerhans cells by engagement of the high affinity receptor for IgE. J Immunol 1995;155:5184-9.
75. 75. Geiger E, Magerstaedt R, Jorg HM, Weendorf JHM, Kraft S, Hanau D, et al. IL-4 induces the intracellular expression of the a chain of the high-affinity receptor for IgE in in vitro-generated dendritic cells. J Allergy Clin Immunol 2000;105:150-6.
76. 76. Maurer D, Fiebiger S, Ebner C, Reininger B, Fischer GF, Wichlas S, et al. Peripheral blood dendritic cells express Fc epsilon RI as a complex composed of Fc epsilon RI alpha-and Fc epsilon RI gamma-chains and can use this receptor for IgE-mediated allergen presentation. J Immunol 1996;157:607-16.
77. 77. Sicherer SH, Sampson HA. Food hypersensitivity and atopic dermatitis: pathophysiology, epidemiology, diagnosis, and management. J Allergy Clin Immunol 1999;104(Suppl):S114-22.
78. 78. Sampson HA. Food allergy, I: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999;103:717-28.
79. 79. Eigenmann PA, Sicherer SH, Borkowski TA, Cohen BA, Sampson HA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998;101:e8.
80. 80. Guillet G, Guillet MH. Natural history of sensitizations in atopic dermatitis. Arch Dermatol 1992;128:187-92.
81. 81. Zeiger R, Heller S. The development and prediction and of atopy in high-risk children: follow-up at seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol 1995;95:1179-90.
82. 82. Sigurs N, Hattevig G, Kjellman B. Maternal avoidance of eggs, cow's milk, and fish during lactation: effect on allergic manifestation, skin-prick tests and specific IgE antibodies in children at age 4 years. Pediatrics 1992;89:735-9.
83. 83. Magnarin M, Knowles A, Ventura A, Vita F, Fanti L, Zabucchi G. A role for eosinophils in the pathogenesis of skin lesions in patients with food-sensitive atopic dermatitis. J Allergy Clin Immunol 1995;96:200-8.
84. 84. May CD. Objective clinical and laboratory studies of immediate hypersensitivity reactions to foods in asthmatic children. J Allergy Clin Immunol 1976;58:500-15.
85. 85. van Reijsen FC, Felius A, Wauters EA, Bruijnzeel-Koomen CA, Koppelman SJ. T-cell reactivity for a peanut-derived epitope in the skin of a young infant with atopic dermatitis. J Allergy Clin Immunol 1998; 101:207-9.
86. 86. Reekers R, Busche M, Wittmann M, Kapp A, Werfel T. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol 1999;104:466-72.
87. 87. Abernathy-Carver KJ, Sampson HA, Picker LJ, Leung DYM. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J Clin Invest 1995;95:913-8.
88. 88. Wheatley LM, Platts-Mills TAE. The role of inhalant allergens in atopic dermatitis. In: Leung DYM, Greaves M, editors. Allergic skin diseases: causes and treatment. New York: Marcel Dekker; 2000. p 423-34.
89. 89. Walker IC. Causation of eczema, urticaria, and angioneurotic edema by proteins other than those derived from foods. JAMA 1918;70:897-900.
90. 90. Tuft L, Heck VM. Studies in atopic dermatitis, IV: importance of seasonal inhalant allergens, especially ragweed. J Allergy 1952;23:528-40.
91. 91. Tupker RA, De Monchy JG, Coenraads PJ, Homan A, van der Meer JB. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol 1996;97:1064-70.
92. 92. Fischer B, Yawalkar N, Brander KA, Pichler WJ, Helbling A. Coprinus comatus (shaggy cap) is a potential source of aeroallergen that may provoke atopic dermatitis. J Allergy Clin Immunol 1999;104:836-41.
93. 93. Clark RA, Adinoff AD. The relationship between positive aeroallergen patch test reactions and aeroallergen exacerbations of atopic dermatitis. Clin Immunol Immunopathol 1989;53(Suppl):S132-40.
94. 94. Tan BB, Weald D, Strickland I, Friedmann PS. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis Lancet 1996;347:15-8.
95. 95. Scalabrin DM, Bavbek S, Perzanowski MS, Wilson BB, Platts-Mills TA, Wheatley LM. Use of specific IgE in assessing the relevance of fungal and dust mite allergens to atopic dermatitis: a comparison with asthmatic and nonasthmatic control subjects. J Allergy Clin Immunol 1999;104:1273-9.
96. 96. Schafer T, Heinrich J, Wjst M, Adam Heinrich, Ring J, Wichmann H-E. Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. J Allergy Clin Immunol 1999;104:1280-4.
97. 97. van Reijsen FC, Bruijnzeel-Koomen CA, Kalthoff FS, Maggi E, Romagnani S, Westland JK, et al. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotypc in patients with atopic dermatitis. J Allergy Clin Immunol 1992;90:184-93.
98. 98. Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol 1988;119:189-98.
99. 99. Bunikowski R, Mielke M, Skarabis H, Herz U, Bergmann RL, Wahn U, Renz H. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol 1999;103:119-24.
100. 100. Nomura I, Tanaka K, Tomita H, Katsunuma T, Ohya Y, Ikeda N, et al. Evaluation of the Staphylococcal exotoxins and their specific IgE in childhood atopic dermatitis. J Allergy Clin Immunol 1999;104:441-6.
101. 101. Strickland I, Hauk PJ, Trumble AE, Picker U, Leung DY. Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. J Invest Dermatol 1999;112:249-53.
102. 102. Bunikowski R, Mielke MEA, Skarabis H, Worm M, Anagnostopoulos J, Kolde G, et al. Evidence for a disease promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 2000;105:814-9.
103. 103. Here U, Schnoy N, Borelli S, Weigl L, Kasbohrer U, Daser A, et al. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol 1998;110:224-31.
104. 104. Hauk PJ, Hamid QA, Chrousos GP, Leung DYM. Induction of corticosteroid insensitivity in human peripheral blood mononuclear cells by microbial superantigens. J Allergy Clin Immunol 2000;105:726-31.
105. 105. Hofer MF, Harbeck RJ, Schlievert PM, Leung DYM. Staphylococcal toxins augment specific IgE responses by atopic patients exposed to allergen. J Invest Dermatol 1999;112:171-6.
106. 106. Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 1996;132:27-33.
107. 107. Skov L, Olsen JV, Giorno R, Schlievert PM, Baadsgaard O, Leung DVM. Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. J Allergy Clin Immunol 2000;105:820-6.
108. 108. Michie CA, Davis T. Atopic dermatitis and staphylococcal superantigens [letter]. Lancet 1996;347:324.
109. 109. Leung DYM, Gately M, Trumble A, Ferguson-Darnell B, Schlievert PM, Picker LJ. Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen (CLAJ. J Exp Med 1995;181:747-53.
110. 110. de Vries U, Langeveld-Wildschut EG, van Reijsen FC, Dubois GR, van den Hoek JA, Bihari IC, et al. Adhesion molecule expression on skin endothelia in atopic dermatitis: effects of TNF-alpha and IL-4. J Allergy Clin Immunol 1998;102:461-8.
111. 111. Jensen-Jarolim E, Poulsen L, With H, Kieffer M, Ottevanger V, Skov P. Atopic dermatitis of the face, scalp and neck: type I reaction to the yeast Pityrosporum ovale? J Allergy Clin Immunol 1992;89:44-51.
112. 112. Back O, Scheynius A, Johansson SG. Ketoconazole in atopic dermatitis: therapeutic response is correlated with decrease in serum IgE. Arch Dermatol Res 1995;287:448-51.
113. 113. Kolmer HL, Taketomi EA, Hazen KC, Hughs E, Wilson BB, Platts-Mills TA. Effect of combined antibacterial and antifungal treatment in severe atopic dermatitis. J Allergy Clin Immunol 1996;98:702-7.
114. 114. Keller P. Beitrag zu den Beziehungen von Asthma und Ekzem. Arch Derm Syph Berl 1924;148:82-91.
115. 115. Hampton SF, Cooke RA. The sensitivity of man to human dander, with particular reference to eczema (allergic dermatitis). J Allergy 1941;13:63-76.
116. 116. Hashem N, Sedlis E, Hirschom K, Emmett Holt E. Infantile eczema: evidence of autoimmunity to human skin. Lancet 1963;2:269-70.
117. 117. Valenta R, Seiberler S, Nattier S, Mahler V, Mossabeb R, Ring J, et al. Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000;105:432-7.
118. 118. Valenta R, Natter S, Seiberler S, Wichlas S, Maurer D, Hess M, et al. Molecular characterization of an autoallergen, Horn s I, identified by serum IgE from atopic dermatitis patients. J Invest Dermatol 1998;111:1178-83.
119. 119. Grewe M, Czech W, Morita A, Werfel T, Klammer M. Kapp A, et al. Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol 1998;161:415-20.
120. 120. Bright JJ, Xin Z, Sriram S. Superantigens augment antigen-specific Th1 responses by inducing IL-12 production in macrophages. J Leukoc Biol 1999;65:665-70.
121. 121. Lacy P, Mahmudi-Azer S, Bablitz B, Hagen SC, Velazquez JR, Man SF, et al. Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. Blood 1999;94:23-32.
122. 122. Ochiai K, Tanabe E, Ishihara C, Kagami M, Sugiyama T, Sueishi M, et al. Role of JAK2 signal transductional pathway in activation and survival of human peripheral eosinophils by interferon-gamma (IFN-gamma). Clin Exp Immunol 1999;118:340-3.
123. 123. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J Invest Dermatol 1991;96:523-6.
124. 124. Hanifin JM, Tofte SJ. Update on therapy of atopic dermatitis. J Allergy Clin Immunol 1999;104:S123-5.
125. 125. Van Der Meer JB, Glazenburg EJ, Mulder PG, Eggink HF, Coenraads PJ. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. Br J Dermatol 1999;140:1114-21.
126. 126. Simons FE. Prospective, long-term safety evaluation of the HI-receptor antagonist cetirizine in very young children with atopic dermatitis, ETAC Study Group: early treatment of the atopic child. J Allergy Clin Immunol 1999;104:433-40.
127. 127. Hanifin JM, Schneider LC, Leung DYM, Ellis CN, Jaffe HS, Izu AE, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28):189-97.
128. 128. Ellis CN, Stevens SR, Blok BK, Taylor RS, Cooper KD. Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement. Clin Immunol 1999;92:49-55.
129. 129. Paukkonen K, Fraki J, Horsmanheimo M. Interferon-alpha treatment decreases the number of blood eosinophils in patients with severe atopic dermatitis. Acta Derm Venereol 1993;73:141-2.
130. 130. Mazer BD, Gelfand EW. An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma. J Allergy Clin Immunol 1991;87:976-83.
131. 131. Spahn JD, Leung DYM, Chan MT, Szefler SJ, Gelfand EW. Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin. J Allergy Clin Immunol 1999;103:421-6.
132. 132. Jolies S, Hughes J, Rustin M. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis. J Am Acad Dermatol 1999;40:121-3.
133. 133. Carucci JA, Washenik K, Weinstein A, Shupack J, Cohen DE. The leukotriene antagonist zafirlukast as a therapeutic agent for atopic dermatitis. Arch Dermatol 1998;134:785-6.
134. 134. Kane JA, Kane SP, Jain S. Hepatitis induced by traditional Chinese herbs: possible toxic components. Gut 1995;36:146-7.
135. 135. Keane FM, Munn SE, du Vivier AW, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999;318:563-4.
136. 136. Fung AY, Look PC, Chong LY, But PP, Wong E. A controlled trial of traditional Chinese herbal medicine in Chinese patients with recalcitrant atopic dermatitis. Int J Dermatol 1999;38:387-92.
137. 137. Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, et al. FK-506, a novel immunosuppressant isolated from a Streptomyces, 1: fermentation, isolation, and physicochemical and biological characteristics. J Antibiol (Tokyo) 1987;40:1249-55.
138. 138. Fleischer AB. Treatment of atopic dermatitis: role of tacrolimus ointment as a topical noncorticosteroidal therapy. J Allergy Clin Immunol 1999;104(Suppl):S126-30.
139. 139. Boguniewicz M, Fiedler VC, Rainier S, Lawrence ID, Leung DYM, Hanifin JM. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children: Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998;102:637-44.
140. 140. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, et al. A short-term trial of tacrolimus ointment for atopic dermatitis: European Tacrolimus Multicenter Atopic Dermatitis Study Group. N EngI J Med 1997;337:816-21.
141. 141. Reitamo S, Rissanen J, Remitz A, Granlund H, Erkko P, Elg P, et al. Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 1998;111:396-8.
142. 142. Grassberger M, Baumruker T, Enz A, Hiestand P, Hultsch T, Kalthoff F, et al. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. Br J Dermatol 1999;141:264-73.
143. 143. Van Leent EJ, Graber M, Thurston M, Wagenaar A, Spuls PI, Bos JD. Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. Arch Dermatol 1998; 134:805-9.
144. 144. Mauser PJ, Pitman A, Witt A, Fernandez X, Zurcher J, Kung T, et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am Rev Respir Dis 1993;148:1623-7.
145. 145. Mauser PJ, Pitman AM, Fernandez X, Foran SK, Adams GK III, Kreutner W, et al. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am J Respir Crit Care Med 1995;152:467-72.
146. 146. Garrone P, Djossou O, Galizzi JP, Banchereau J. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur J Immunol 1991;21:1365-9.
147. 147. Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, et al. Interleukin-4 receptor in moderate atopic asthma. Am J Respir Crit Care Med 1999;160:1816-23.
148. 148. Milgrom H, Fick RB Jr, Su JQ, Reimann JD, Bush RK, Watrous ML, et al. Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 1999;341:1966-73.